Skip to content

    Recently Viewed


      Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (August 17, 2020) -- Johnson & Johnson (NYSE: JNJ) will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, September 9th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 10:40 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at

      A webcast replay will be available approximately two hours after the live webcast.

      Press Contacts:
      Cristal Downing
      (732) 524-3283
      (908) 616-6250 (M)

      Investor Contacts:
      Jennifer McIntyre
      (732) 524-3922

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.